Value Health Voices

American families now spend roughly one fifth of their income on health premiums, and if current trends hold, that number could reach 40 percent by 2032. In this episode of Value Health Voices, Dr. Amar Rewari and Dr. Anthony Paravati sit down with Joel White, president of the Council for Affordable Health Coverage and former staff director of the House Ways and Means Health Subcommittee, to understand why the system keeps charging more while delivering narrower networks, higher cost sharing, and more prior authorization friction.Joel argues that the United States does not have a free market in health care at all, but a system of localized monopolies shaped by regulation. He walks through how the medical loss ratio rule became a consolidation engine for vertically integrated insurers, how 340B drifted from a safety net program into what he calls a scam that never reaches the patient, and why pharmacy benefit managers capture roughly half of every dollar spent on drugs. Along the way, he explains what the PBM law signed earlier this year actually changes, why CMS is pushing site neutral payment into imaging, and why he believes fee-for-service medicine is a relic that should be retired.The conversation closes with Joel's five pillar agenda for affordability: real price and quality transparency, giving consumers the freedom to choose any approved plan, sending subsidies to people instead of insurers, driving down underlying medical costs through simpler value-based models, and restoring competitive markets through antitrust enforcement and more independent practice. Whether you lead a health system, run a practice, or simply pay a premium every month, this episode offers a clear map of the reforms that could reshape what care costs in the next few years.Resources:【Council for Affordable Health Coverage Policy Priorities】【Patients Deserve Price Tags Act (S.3548)】【Association Health Plans Act (H.R. 2868)】【LinkedIn】【Instagram】【TikTok】【Newsletter】【Apple Podcasts】【Spotify】

Dr. Ezekiel "Zeke" Emanuel helped design the Affordable Care Act, and 16 years later he has a surprising answer to what he would change: the law made an already impossible system even more complicated. In this episode of Value Health Voices, Drs. Anthony Paravati and Amar Rewari sit down with the oncologist, medical ethicist, and University of Pennsylvania professor for a wide-ranging conversation on what the ACA got right, what it got wrong, and why he believes the next wave of reform has to be built on three mantras: simplification, standardization, and digitization.From there the conversation runs through the greatest hits of health policy frustration. Zeke explains why the IRA drug negotiations were not the home run the country needed, how the biologic and small molecule patent protection timelines quietly bias the market toward more expensive drugs, and why he would scrap 340B entirely in favor of direct subsidies and a tax on manufacturers. The three physicians also dig into the RUC and physician fee schedule, radiation oncology's failed bundled payment experiment and the new ROCR proposal, percentage-based reimbursement for drugs that have driven up drug prices, and the growing evidence that private equity has yet to improve cost or quality anywhere in medicine.The episode closes with two of Zeke's most provocative arguments. Drawing on his new JAMA review of more than 100 studies, he makes the case that autonomous AI already matches or beats physicians in six core clinical areas, and that keeping a doctor in the loop will eventually degrade care rather than improve it. Then he turns personal, sharing which rule from his book Eat Your Ice Cream doctors most overlook and explaining why, more than a decade after writing "Why I Hope to Die at 75," his number has not moved.Resources:【Dr. Ezekiel Emanuel Website】【"Eat Your Ice Cream" By. Dr. Emanuel】【LinkedIn】【Instagram】【TikTok】【Newsletter】【Apple Podcasts】【Spotify】

Mark Cuban did not set out to become the most disruptive force in American drug pricing. He just wanted to know why the same generic pill could cost $15 at one pharmacy and $500 at another. In this episode of Value Health Voices, Mark tells Dr. Anthony Paravati and Dr. Amar Rewari exactly what he found when he peered under the hood of the pharmacy supply chain, and why his answer was to launch Cost Plus Drugs with a radically simple promise: show patients the real cost, add a fair markup, and sell trust instead of marketing.The conversation goes deep into the machinery most patients never see. Mark breaks down how pharmacy benefit managers profit from rebates, spread pricing, and formulary threats, why brand manufacturers privately admit they cannot work with him, and how vertically integrated conglomerates shuffle billions between their own subsidiaries. He shares the story of a heart transplant patient whose life depended on a $200 generic her employer's plan refused to cover, and explains why he now spends his time telling CEOs to run their PBM contracts through AI and ask one question: where am I getting ripped off?Mark also lays out his blueprint for reform, including deductible credit for cash purchases, real consequences for repeat offenders, federally guaranteed healthcare loans, and full contract transparency. He makes the case for direct contracting between hospitals and self-insured employers, explains why he believes real change comes from outside Washington, and settles the question everyone keeps asking: whether he will run for president. This is a candid, unfiltered look at the business of American healthcare from the one outsider who decided to fix it himself.Episode Resources:Mark Cuban’s Cost Plus Drug CompanyCost Plus Wellness for Self-Insured EmployersJAMA Study on Potential Savings via Cost Plus Drugs

A physician's mother called her, worried. She'd seen a video of her daughter selling a weight loss product. Her daughter had never made the video - a scammer had cloned her face. That's where we start with Dr. John Whyte, CEO of the American Medical Association, who calls deepfake doctors a rapidly developing public health crisis and has taken it on with an unlikely partner: SAG-AFTRA. As he tells it, members of Congress noticed that when the actors' guild and the physicians' lobby land on the same side, you're probably right.Underneath the fakes is the harder question - trust, and who has standing to give medical advice at all. Whyte's line: social media is the only place where you don't need a license to practice. We push him on where that line actually falls. In Utah, AI now renews prescriptions with no physician in the loop, and he doesn't hedge: the tech industry has become the tail wagging the dog, solving for problems nobody established were problems. But this isn't an anti-AI hour. He gets genuinely animated about what he wants built - an AI second opinion for every patient with a cancer diagnosis, closing the gap between rural and urban, community center and cancer center. Physician in the loop, patient in the loop.We also cover the money: budget neutrality, why physician payment still isn't tied to inflation, and whether real reform is close or this is just SGR with better manners. Plus the AMA's sharpened stance on private equity, and the prior auth bot wars - physicians using AI to appeal denials that insurers' AI wrote in the first place. Then we ask him the question worth asking: knowing all of it, would you do medicine again?

Transitioning from directing Medicare for 170 million Americans to managing a $20 billion state healthcare budget requires a unique blend of clinical, economic, and policy expertise. In this episode, Dr. Meena Seshamani, Secretary of the Maryland Department of Health and former Director of CMS, joins the show to break down the complex forces shaping state and federal healthcare finance. Listeners will gain an exclusive insider’s perspective on how aligning incentives and investing in population health can fundamentally transform patient care while driving sustainable systemic savings. Dr. Seshamani unpacks her pivotal role in launching the historic Medicare drug price negotiation program, revealing how utilizing real-world data and cross-industry collaboration led to billions in initial savings. The conversation also explores the strategic push to establish reimbursement structures for wraparound services - like community health workers and care navigators - to address the social determinants of health directly through the physician fee schedule. Furthermore, she details the evolution of Maryland's unique all-payer model and its current transition to the AHEAD model, prompting a critical question: could this localized approach to value-based care and global hospital budgets serve as the ultimate blueprint for the rest of the nation? If you want to stay ahead of the policies and payment models redefining the medical industry, hit subscribe and leave a review for Value Health Voices!